Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
about
Co-infection subverts mucosal immunity in the upper respiratory tractPneumococcal Capsules and Their Types: Past, Present, and FutureEscherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.Pathogenesis and pathophysiology of bacterial meningitis.Comparative immunogenicity of group 6 pneumococcal type 6A(6) and type 6B(26) capsular polysaccharides.Haemophilus influenzae type b conjugate vaccines.Effect of neonatal gastrointestinal colonization with cross reacting Escherichia coli on anticapsular antibody production and bacteremia in experimental Haemophilus influenzae type b disease of rats.Experimental Haemophilus influenzae type b meningitis: immunological investigation of the infant rat model.Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivityAssociation between cross-reacting Escherichia coli K100 and disease caused by Haemophilus influenzae type bEnzyme-linked immunosorbent assay for detection and quantitation of capsular antigen of Haemophilus influenzae type b.Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.Uncommon Haemophilus infections.Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type b in human adult volunteers.The human antibody V region repertoire to the type B capsular polysaccharide of Haemophilus influenzae.Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease.Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations.Social mixing with other children during infancy enhances antibody response to a pneumococcal conjugate vaccine in early childhood.The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in MaliProtection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenaseAntibody response to polyribosyl-ribitol phosphate antigen of Haemophilus influenzae in Ecuadorian and German children.A mucosal antibody response following systemic Haemophilus influenzae type B infection in childrenQuantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.The effect of complement depletion on lung clearance of bacteria.Role of nasopharyngeal colonization with and without bacteremia in the protection of infant rats against Haemophilus influenzae type b challenge.Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugatesLatex agglutination test for screening of Haemophilus influenzae type b carriers.Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States.Chemical structure, conjugation, and cross-reactivity of Bacillus pumilus Sh18 cell wall polysaccharide.Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate)Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicatorHaemophilus influenzae: immunology and immunoprotection.Infectious diseases and aging: immunologic perspectives.Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli.Counterimmunoelectrophoresis in biology and medicine.Vaccine-induced immunologic memory and pace of pathogenesis: predicting the need for boosters.Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study
P2860
Q27002952-8CA579D2-9563-4555-A1A8-4A398C157FFEQ27006887-8AC6E016-045A-4C0A-94AA-586DF1530513Q30442755-6C8B6D10-E250-4DA8-B17F-397BCA1E3F32Q30450181-A4AC4066-A2E4-4C35-86C1-A81DD204F8B1Q34101106-2942251E-CEB4-4110-9CE4-43CB780F419AQ34349892-FB768984-E317-4C49-93B2-5E985F2CEC80Q34411354-619B176E-258C-4E87-BFF0-29B18E4D706FQ34447565-8BC88E3A-1D30-4A8D-A541-B52544F273B4Q34453364-491B0008-F71D-41AE-8D7E-27492C178EC9Q34459413-604A9E6C-67AE-4087-86E6-E4348F242EB2Q34461334-A1C15850-E461-4957-BA9B-B7857028F6A1Q34483171-E0498887-07C5-476E-853C-1B96CDAC3C0CQ34531792-AADF13BD-28A3-4039-A060-93F7DAAA1035Q34553231-04658702-A6B9-4963-B1C8-A3A502BC5F9EQ34720237-9DD7B448-535E-4CDA-93C1-2D4E4BFE317AQ35023397-5F757545-7C96-4035-AAB0-DE7C40DB5C17Q35163997-1234FBA0-E127-4159-8EB9-F8CE91B876EBQ35287762-49B8B9B4-477E-417C-AE72-C2D264969E4AQ35598710-A37B28A6-D70F-45F0-A89C-531F3C64A322Q35783574-3CD9F4CC-7D6D-4613-AFFE-86B0106D3299Q35904953-EF7E4890-DBF2-4D76-A733-B640B0A5963BQ36005810-010C2DBC-2526-4290-994F-29CF28952F06Q36187255-9CE793D4-1CCF-4D83-ACA3-7DD33CFAF569Q36927099-6386DA5B-F925-4922-85B0-E8EF77C1BABBQ36999138-4DF7844D-8CED-4A2F-A96B-71BCB6B88407Q37029301-A1305B4F-7290-4FDE-8574-FD9CAB9F25BFQ37030806-1F86B259-AE04-4666-BCDE-E0B74D060B6EQ37036026-FAC80081-322D-49A5-BC67-9BB48CD63D1EQ37110954-C244D601-5A87-478D-B61C-AA4C19213452Q37214743-8D1E7AE3-801B-439B-BD29-22EDA7A0CC4DQ37252348-4212B65B-DB19-44E6-A6C3-050CE30CC5A7Q37573805-68E8433F-5BF5-4DA1-8CB0-A7F4D8A8C078Q39508902-A621EBC5-21CF-47CC-82FD-A2C5236A444FQ39673513-666F5EBA-3E24-451B-8703-DB84C86ADC7DQ39773982-A91ACD58-0701-46BF-BE36-954863D73860Q40166495-C7AE8273-7D2E-4435-95FE-F6337F54DF0BQ40177628-166412E5-A94F-42E8-88E3-4B3680BCBA65Q41219457-42FB1B94-4FB9-457A-9827-155714749059Q51960916-A1A30F41-9AA7-4DCA-B573-F4DAB85765E7Q58778863-144B73BB-1804-4EA1-8652-ACAFCF26E52C
P2860
Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@en
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@nl
type
label
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@en
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@nl
prefLabel
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@en
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@nl
P1476
Induction of serum Haemophilus ...... Escherichia coli 075:K100:H5.
@en
P2093
Robbins JB
Schneerson R
P304
P356
10.1056/NEJM197505222922103
P407
P577
1975-05-01T00:00:00Z